trial · primary record
GKL-006 injection
Advanced Pancreatic Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 52 |
| Primary completion | 2027-08-31 |
| Primary endpoint | Phase I: Incidence of Dose-Limiting Toxicities |
| Registry ID | NCT07777211 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:59.502Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07777211
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.